Sodium Nitroprusside Injection Shortage
Last Updated: October 11, 2017
Status: Resolved
Reason for the Shortage
-
- Akorn has sodium nitroprusside 25 mg/mL 2 mL vials available.
- Exela launched Nipride RTU 0.5 mg/mL 100 mL vials in March 2017.
- Nexus has sodium nitroprusside 25 mg/mL 2 mL vials available.
- Sagent has sodium nitroprusside 25 mg/mL 2 mL vials available.
- Valeant has Nitropress available.
Available Products
-
- Nipride RTU injection, Exela Pharma Sciences, 0.5 mg/mL, 100 mL ready-to-use vial, 1 count, NDC 51754-1006-01
- Nitropress injection, Valeant, 25 mg/mL, 2 mL vial, 1 count, NDC 00187-4302-02
- Sodium Nitroprusside injection, Akorn, 25 mg/mL, 2 mL vial, 1 count, NDC 17478-0014-02
- Sodium Nitroprusside injection, Nexus Pharmaceuticals, 25 mg/mL, 2 mL vial, 1 count, NDC 14789-0012-02
- Sodium Nitroprusside injection, Sagent, 25 mg/mL, 2 mL vial, 1 count, NDC 25021-0310-02
Estimated Resupply Dates
-
- All presentations are available.
Updated
Updated October 11, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 30, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.